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Emerging Infections Program Network 
Streptococcus pneumoniae, 2015
ABCs Areas 
California (San Francisco County and children < 18 years, 
adults ≥ 65 years in Alameda and Contra Costa counties); 
Colorado (5 county Denver area); Connecticut;  Georgia 
(20 county Atlanta area); Maryland (6 county Baltimore 
area); Minnesota; New Mexico; New York (15 county 
Rochester and Albany areas and children <5 years in Erie 
county); Oregon (3 county Portland area); Tennessee (20 
counties).  
ABCs Population 
The surveillance areas represent 31,977,800 persons. 
Source: National Center for Health Statistics bridged-race 
vintage 2015 postcensal file 
ABCs Case Definition 
Invasive pneumococcal disease: isolation of Streptococcus 
pneumoniae from normally sterile site in resident of a 
surveillance area in 2015.  
ABCs Methodology 
ABCs personnel routinely contacted all microbiology 
laboratories serving acute care hospitals in their area to 
identify cases. Standardized case report forms that include 
information on demographic characteristics, clinical 
syndrome, and outcome of illness were completed for each 
identified case.  Pneumococcal isolates were collected and 
sent to reference laboratories for susceptibility testing 
using CLSI methods and serotyping. Regular laboratory 
audits assessed completeness of active surveillance and 
detected additional cases. 
Rates of  invasive pneumococcal disease were calculated 
using population estimates for 2015 from the bridged-race 
vintage 2015 postcensal file. For national estimates, 
race- and age-specific rates of disease were applied from 
the aggregate surveillance area to the age and racial 
distribution of the 2015 U.S. population.  Cases with 
missing data, excluding ethnicity, were multiply imputed 
using sequential regression imputation methods.¶ 
Reported ABCs Profiles 
Race No.    (Rate*)
White 2,089     (8.7) 
Black 683   (12.8) 
Other 171     (6.6) 
*Per 100,000 population for ABCs areas
¶ Surveillance Note 
 Missing race (n=304) data were multiply imputed using 
sequential regression imputation methods.  
+ Penicillin CLSI breakpoints changed in 2009
Cases Deaths 
Age (years)      No. (Rate*)  No.   (Rate*)
< 1 77 (18.4) 1 (0.24) 
  1 54 (12.9) 1 (0.24) 
2-4 65 (5.1) 2 (0.16) 
5-17 70 (1.3) 0 (0.00) 
18-34 179 (2.5) 6 (0.08) 
35-49 416 (6.7) 31 (0.50) 
50-64 924 (15.0) 94 (1.53) 
65-74 497 (18.2) 63 (2.30) 
75-84 379 (29.0) 59 (4.50) 
≥ 85 282 (45.3) 72 (11.56) 
Total 2,943 (9.2) 329 (1.03) 
*Per 100,000 population for ABCs areas
Syndrome     No.   (%*)
Meningitis 208         (7.1) 
Bacteremia without focus 500     (17.0) 
Pneumonia with bacteremia 2,003     (68.1) 
* Percent of cases
Antibiotic S* I† R‡ 
Susceptibility % % % 
Penicillin+ 95.7 2.0 2.4 
Cefotaxime 97.6 2.0 0.4 
Erythromycin 69.6 0.2 30.1 
TMP/Sulfa 81.4 10.9 7.7 
Tetracycline 88.9 0.2 10.9 
Levofloxacin 99.9 0.0 0.1 
Vancomycin 100 
Based on reference lab testing of 2,511 isolates. 
* Susceptible; † Intermediate; ‡ Resistant based on year 2014
CLSI definitions
National Estimates of Invasive Disease
Cases:  29,500   (9.2/100,000) 
Deaths:    3,350   (1.04/100,000) 
Healthy People 2020 Update 
Objective: Decrease the incidence of invasive pneumococcal 
infections to 12 per 100,000 persons less than 5 years of age 
and to 31 per 100,000 persons aged 65 and older. 
Age (year) 2020 Objective 2015 Rate*
< 5     12/100,000  9/100,000 
≥ 65     31/100,000  25/100,000 
*Per 100,000 U.S. population < 5 years or ≥ 65 years
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